Urine-based autism screening using gut microbial metabolites
A pilot study suggests that measuring gut-derived metabolites in urine could serve as a non-invasive screening tool for autism spectrum disorder. Researchers hope this discovery will help identify distinct biological subtypes of autism, potentially enabling earlier diagnosis and more targeted interventions.
Why it matters
Early diagnosis of autism is currently difficult, and this biomarker could significantly improve clinical outcomes by allowing for earlier behavioral interventions.
Urine-based autism screening using gut microbial metabolites
The article reports on scientific findings in a neutral, objective tone without political or social commentary.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in